News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cypress Bioscience Inc. (CYPB) Sells Diagnostics Business Exagen Diagnostics, Inc. for up to $8 Million


10/11/2010 7:28:43 AM

Xconomy -- San Diego’s Cypress Bioscience (NASDAQ: CYPB), has agreed to sell its diagnostices business to Albuquerque, NM-based Exagen Diagnostics for as much as $8 million in upfront and milestone payments, with additional future payments in the form of royalties on product sales. Exagen Diagnostics, which specializes in the discovery and development of genomic marker tests, is acquiring Cypress Bio’s diagnostic business in its entirety, and will assume the lease for all lab operations in San Diego. The company said all of Cypress Bio’s lab employees will be offered positions with Exagen.

Read at Xconomy
Read at Trading Markets.com
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES